ISHLT 2023: Baroreflex Activation Therapy: Insights from the BeAT-HF Trial

ISHLT 2023: BeAT-HF Clinical Trial by Dr. Brian HowardПодробнее

ISHLT 2023: Piedmont Heart Institute Experience with Barostim by Dr. Robert T ColeПодробнее

ISHLT 2023: Baroreflex Activation Therapy for HFrEF by Dr. Luanda GrazetteПодробнее

THT 2022: Barostim Clinical Trial Results and Clinical Experience by Dr. Nirav RavalПодробнее

ESC 2023: Real-world experience with Baroreflex Activation Therapy by Dr. Fernando ArribasПодробнее

HRS 2023: What’s Next for Baroreflex Activation Therapy by Dr. Anne KromanПодробнее

ISHLT 2023: Our Experience with Barostim in over 40 Patients to Date by Dr. Patrick McCannПодробнее

Baroreflex Activation Therapy: A Novel Approach for HFrEF PatientsПодробнее

ESC 2023: BeAT-HF: Long term outcomes by Dr. Michael R. ZileПодробнее

THT 2022: The Mechanism of Action and Role of Baroreflex Activation Therapy by Dr. Marat FudimПодробнее

HRS 2023: Barostim in the EP’s HFrEF Toolbox by Dr. Rizwan AlimohommadПодробнее

HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart Failure PatientsПодробнее

THT 2022: The Need for Device Therapy in HFrEF by Dr. William AbrahamПодробнее

HRS 2022: Barostim Case Experience and Evolving the Implant Procedure by Dr. James AllredПодробнее

ESC 2023: Unmet needs and opportunities with device therapies of HFrEF by Dr. William AbrahamПодробнее

HealthWatch: Barostim Heals Heart FailureПодробнее

Barostim Device ImplantationПодробнее

Jagmeet P. Singh | Advances in Electrical Therapies for Heart FailureПодробнее

BASHIR™ Mechanism of Action VideoПодробнее